Emilia Development 2025: Overseas Holds the Group Together, Chemobile Still Drags

Company Introduction

At first glance, Emilia Development looks like a diversified holding company: Mendelson in flow-control and sanitation products, Chemobile in industrial services, Overseas in logistics, plus Plazit, Tene and other financial holdings. But 2025 makes the picture much sharper: Overseas was the unit that held the year together, while Chemobile was the main reason the bottom line weakened.

That is the heart of the story. Consolidated revenue rose to NIS 2.098 billion, up 1.6%, but profit attributable to shareholders fell to NIS 34.3 million, down 42%. Anyone looking only at the top line will see mild growth. Anyone digging one layer deeper will see a sharp profit mix shift: Overseas accelerated and improved profitability, Mendelson stayed profitable but weakened versus last year, and Chemobile lost altitude across almost every important metric.

What is still working now? The operating base is still broad. The group produced EBITDA of NIS 292.6 million and operating cash flow of NIS 248 million. What is still not clean? Access to value. At the parent-company level, solo cash at year end was only about NIS 6.4 million against NIS 89.2 million of bank debt. So the real question is not whether the group owns good businesses. The real question is which businesses are currently generating clean cash that can actually move up the chain without reducing flexibility.

That is also the early screen for investors. As of April 6, 2026, market cap stood at about NIS 656 million, but turnover on the latest trading day was only NIS 2,747. One day does not prove a structural liquidity problem by itself, but it does remind readers that this is not a stock with deep day-to-day market depth. On the other hand, short-interest data is effectively nil, with short float at 0.00% and SIR at 0.14 at the end of March 2026. In other words, this is not a technical short story. It is a fundamental one: can Chemobile recover, and can the parent keep seeing real upstream cash from the group.

The Group's Economic Map

The right way to read Emilia in 2025 is not through the legal chart, but through the profit engines:

One more data point helps frame the business. The group employs roughly 1,700 people if we add 559 at Mendelson, 714 at Chemobile, 394 at Overseas and about 30 at the parent. This is not a light holding company that merely allocates capital. It is a real operating group. That is why profit quality, working-capital quality and upstream cash access matter here much more than book value alone.

Events And Triggers

The first trigger: the internal restructuring at Chemobile in early 2025 did not solve the economic problem. In January 2025, the internal merger of Chemotal into Chemobile was completed, after which the names were switched and the industrial-services operations continued to be presented as the Chemobile group. That cleans up structure. It does not fix profitability.

The second trigger: Chemobile kept buying activity even while the core weakened. In January 2025 it bought Ronli's hospital-disinfectant business for fixed consideration of NIS 4.5 million plus contingent consideration of up to NIS 1 million. In October 2025 it signed to buy Universal's specialty food-ingredient distribution business for NIS 14.75 million plus contingent consideration of up to NIS 2.5 million, and that deal closed in March 2026. The message is clear: management is trying to broaden the engine through acquisitions as well. The flip side is just as clear: when margins are under pressure, buying activity is also an implicit admission that organic growth alone is not enough right now.

The third trigger: Overseas keeps adding capacity and utilization, but does so inside a more competitive market. New ports and new competing terminals have intensified pressure in FCL, according to Overseas itself. Even so, utilization rose across all three major operating areas in 2025. That is exactly why Overseas matters so much to the thesis: for now, it is proving it can grow even inside a market that is getting tighter.

The fourth trigger: after the balance-sheet date, dividends moved up the chain again. In March 2026 Mendelson approved a NIS 20 million dividend, Overseas approved NIS 2.8 million, Plazit approved NIS 1.59 million of which Emilia's share is about NIS 0.4 million, and the parent itself declared a NIS 5.14 million dividend. This matters because Emilia lives, in practice, on the ability of subsidiaries to generate not only earnings but distributable cash.

The fifth trigger: the group says no direct and specific war impact was identified on 2025 activity, aside from some weakness during the 12-day June 2025 operation. But after year end, the risk backdrop worsened again, with fighting involving Iran and possible effects on fuel costs, sea trade and operating routine. For Emilia, that is not a generic macro paragraph. It directly touches Chemobile's cost base and Overseas' trading environment.

Efficiency, Profitability And Competition

Chemobile: this is where profit quality broke

Chemobile is the main reason the year looks weaker than the revenue line suggests. Revenue fell to NIS 697.0 million from NIS 720.6 million. Gross profit fell to NIS 119.8 million from NIS 140.2 million, and gross margin fell to about 17% from around 19% in each of the prior two years. Operating profit was cut to NIS 26.7 million from NIS 54.3 million.

Management's explanation matters. It ties the deterioration, among other factors, to lower selling prices in part of the portfolio because of the weaker dollar against the shekel, and to one-off projects that supported revenue in 2024 but did not continue into 2025. That is important because this is not just a volume problem. It is a pricing and revenue-quality problem.

There are more clues below the line. According to the board report, finance expense at Chemobile rose by about NIS 5 million, mainly because of FX losses and higher lease-related financing expense. In addition, inventory days rose to 92 from 88, while receivable days fell to 107 from 120. That does not make working capital alarming, but it does show a business that had to work harder to maintain turnover quality.

What is especially interesting is the combination of numbers and headcount. Chemobile ended 2025 with 714 employees, down from 764 at the end of 2024, a reduction of 50 employees, mainly in operations and drivers. In the fourth quarter the company already described a better gross-margin profile due to operating efficiency steps and a roughly NIS 3 million decline in G&A, mainly at Chemobile. That is a sign that management is trying to arrest the erosion through cost action.

The problem is that Chemobile's balance sheet does not leave much room for mistakes. Net debt to EBITDA stood at 3.48 at year end, against a covenant ceiling of 4.5. That is not a breach, but it is also not a comfortable gap compared with Mendelson or Overseas. If 2026 does not bring a real margin and EBITDA recovery, this is the first place where the market will start asking whether Chemobile is still an operating engine or is becoming mainly an internal balancing burden.

Overseas: the unit that saved the year, but not a risk-free one

Overseas delivered the most important positive contribution in 2025. Revenue rose to NIS 377.8 million from NIS 326.0 million, gross profit rose to NIS 87.7 million from NIS 63.9 million, and operating profit jumped to NIS 58.0 million from NIS 39.3 million. Net profit rose to NIS 25.1 million from NIS 11.4 million.

The quality of that improvement matters. It was not just an accounting effect. Utilization itself moved higher: FCL rose to about 88% from 83%, LCL to about 82% from 79%, and integrated logistics to about 83% from 78%. Overseas operated its asset base more effectively, and in this kind of business that tends to translate directly into profitability.

But 2025 should not be read as though Overseas suddenly operates in a clean market. The filing says explicitly that competition in FCL intensified after the new ports opened, that port operators improved terms to keep containers inside the port area, and that additional competing terminals in Haifa increased pressure. Overseas also states that it is already seeing profitability erosion in that activity. On top of that, it says its pricing generally does not exceed the regulated port tariff. So even when volume rises, pricing power is not unconstrained.

That creates the key paradox. Overseas is currently the asset that stabilizes Emilia, but it is doing so inside a market where competition itself is intensifying. So 2025 gives the thesis credibility. It does not finish the proof.

Mendelson: a solid base, but no step-up year

Mendelson remained large and profitable, but 2025 was not a breakout year for it. Revenue rose to NIS 1.039 billion from NIS 1.024 billion, and gross profit edged up to NIS 281.5 million. But operating profit fell to NIS 72.0 million from NIS 84.0 million, and net profit fell to NIS 46.8 million from NIS 54.6 million.

Mendelson still shows several real strengths. It has no dependency on any single customer or material supplier, one of its core production subsidiaries is operating close to full capacity, and operating working capital reached roughly NIS 486 million at year end. But this is exactly why the story should not be softened. Mendelson did not break, yet it also did not turn the better macro backdrop in Israeli construction into an operating acceleration.

For Emilia, the conclusion is simple. Mendelson is currently a stable anchor, not a single engine that can offset a sharp Chemobile deterioration on its own.

Cash Flow, Debt And Capital Structure

The cash flow looks strong, but the all-in cash picture is less flattering

It matters to define the cash frame explicitly. In Emilia's case, the right frame is all-in cash flexibility, not normalized cash generation. The reason is straightforward: the thesis is not only about earning power, but about how much cash is really left after debt service, lease cash and distributions.

On that basis, the picture is mixed. On one hand, operating cash flow rose to NIS 248 million from NIS 195 million. That is impressive, but management also makes clear that part of the improvement came from friendlier working-capital movement versus 2024. On the other hand, that same cash then funded NIS 38 million of investing outflows and NIS 217 million of financing outflows, so consolidated cash fell to NIS 52.1 million from NIS 59.5 million.

The implication is that operating cash flow was strong, but not strong enough to produce real excess cash after the full set of uses. That does not mean the group is under acute pressure. It does mean Emilia should be read through a cash and structure lens, not only an earnings lens.

Who funds the parent

This is one of the keys to the whole story. The parent funds itself through long-term loans, dividends and management fees. At year end it had NIS 89.2 million of bank debt and only about NIS 6.4 million of solo cash. During 2025 it received NIS 51.7 million of internal dividends and management fees from the group, while at the same time paying NIS 17.7 million of dividends to Emilia shareholders.

This is not a distress read, but it is also not a parent with a deep standalone cushion. Emilia's own covenants look comfortable on paper: 89% solo equity-to-assets versus a 40% minimum, about NIS 795 million of attributable equity versus a NIS 400 million floor, and weighted net debt to EBITDA of 1.7 versus a 4.5 ceiling. But the fourth test, which requires solo cash of roughly NIS 3 million at minimum, is a reminder that parent-level liquidity is not unlimited.

Put simply, the value in the group exists. The question is how much of it is truly accessible to Emilia's own shareholders, and how quickly.

The covenants are comfortable, but not equally comfortable everywhere

The easy reading of the filing is that all entities are in compliance. That is true. The more interesting reading is that the cushions are not evenly distributed.

Mendelson sits at 0.9 versus 3.5. Overseas is at 2.1 versus 5.6. The parent is at 1.7 versus 4.5. Chemobile, by contrast, is at 3.48 versus 4.5. So if there is one place inside the group that deserves the most scrutiny in 2026, it is not Mendelson and not Overseas. It is Chemobile.

Outlook

Four things the reader can easily miss

First: Emilia is not entering 2026 as a clean growth story. It is entering as a balancing story. Overseas pushed forward, Mendelson stayed standing, but Chemobile reduced the quality of the entire earnings base.

Second: the stronger operating cash flow does not mean pressure has disappeared across the structure. In reality, after investment, repayment, leases and dividends, consolidated cash still fell, and the parent-level cash cushion remained narrow.

Third: the acquisitions at Chemobile are both an opportunity and an admission. They may open stronger categories, but they do not change the fact that the existing activity deteriorated materially in 2025.

Fourth: 2025 was an excellent year for Overseas in terms of reported results, but the filing itself warns that its core market is getting tighter. So this is not yet a clean transition to a higher steady state. It is a test of durability.

That also defines the next year. 2026 is a proof year. Not a breakout year. Not a reset year. A proof year. Emilia has to prove three things at once: that Chemobile can stop the margin erosion, that Overseas can defend profitability even inside sharper competition, and that the parent can keep pulling real cash upstream without reducing its own flexibility further.

At the operating level, the first sign of improvement has to come from Chemobile. If the efficiency actions that surfaced at the end of 2025 were the beginning of a real fix, that should show up over the next 2 to 4 quarters in a better margin profile, more stable financing expense and some distance from the 3.48 net-debt-to-EBITDA ratio. If that does not happen, the new acquisitions will look more like patchwork than a clean strategic move.

At the group level, Overseas is Emilia's most important card for 2026. It enters the new year with better utilization, broad geographic spread and an operating contribution that is already larger than Chemobile's. But precisely because of that, any sign of price erosion without another step-up in volume will matter quickly to the market.

At the parent level, the post-balance-sheet dividends provide oxygen, not structural change. Dividends from Mendelson, Overseas and Plazit help create upstream flow, but they do not change the fact that solo cash stood at only about NIS 6.4 million at the end of 2025 against NIS 89.2 million of debt.

What can change the market read in the near term? First, evidence that Chemobile stops being a profitability drag. Second, proof that Overseas can keep utilization high without giving away too much on price. Third, confirmation that the parent can preserve distributions without shrinking its own cash flexibility further.

Risks

The first risk is not group leverage, but Chemobile weakness

Chemobile is the most delicate part of the picture: operating profit almost halved, net debt to EBITDA ended the year at 3.48, finance expense rose because of FX losses and leases, and the business is relying on acquisitions to support growth. That is not a break point yet, but it is clearly a yellow flag.

The second risk is that Overseas is performing well inside a market that is becoming more competitive

When the company itself says that new ports and new terminals are intensifying competition and eroding FCL profitability, 2025 cannot be treated as a fixed base case. Overseas is strong, but it still operates in a market where scale does not eliminate competition.

The third risk is the gap between consolidated value and accessible value

Consolidated equity reached NIS 1.132 billion. That is a strong headline number. But for Emilia shareholders, the more important question is how much cash is actually accessible at the parent, and how dependent the company remains on upstream dividends and management fees. In that sense, the solo layer remains a classic holding-company bottleneck.

The fourth risk is external

After the balance-sheet date, fighting involving Iran reopened uncertainty around fuel prices, sea trade and operating routine. For Chemobile this is mainly a cost risk. For Overseas it is a trade-flow and operating-environment risk.

The fifth risk is legal, but not currently the core thesis risk

There is a NIS 6.2 million customer claim at Mendelson for which management says sufficient provision was recorded, another NIS 4.45 million claim at a Mendelson subsidiary where the outcome cannot yet be assessed, and a labor dispute application at Taviv with a NIS 24.6 million monetary demand where the company says any exposure, if it exists, is not material. These items do not currently look like the core driver of the thesis, but they help explain why other expenses were part of the 2025 story.

Conclusions

Emilia ended 2025 as a holding company with a still-strong operating base, but a different internal center of gravity. Overseas carried the year, Mendelson remained reasonably stable, and Chemobile weakened profit quality while reminding readers that for a holding group the key question is not just what is earned, but where the clean cash is left. In the short to medium term, the market will mainly watch whether Chemobile stabilizes and whether Overseas can preserve quality as competition rises.

Current thesis: Emilia is now a balancing story, not a story of equally strong growth engines.
What changed: Overseas moved from secondary support to the group's main balancing asset, while Chemobile moved from being a meaningful profit engine to the main weak point.
Counter-thesis: 2025 may prove to be only a temporary weak year at Chemobile, with efficiency actions and new acquisitions already laying the groundwork for a cleaner 2026.
What can change the market read: a faster Chemobile margin recovery, continued upstream distributions, and evidence that Overseas can keep profitability despite tighter competition.
Why this matters: because at Emilia the gap between accounting value and accessible shareholder value can be large, and 2025 made that gap much clearer.
What must happen next: Chemobile needs to move away from stretched operating leverage, Overseas needs to show that its growth was not bought through deeper price concessions, and the parent needs to keep pulling cash upstream without moving closer to the edge of solo liquidity.